After 6 months, alli has been shown to help more than 46% of people lose at least 5% of their initial body weight
Many patients were not informed by Novo Nordisk or their doctors that blindness caused by NAION was a potential complication
The US Department of Health and Human Services (HHS) sets the Poverty Guidelines annually
A role for glucagonlike peptide1 in the central regulation of feeding
We observed an initial blunted response at time points 10 ( BrAC Control = 0.037, BrAC GLP-1RA = 0.021, t(113) = 3.21, p = 0.014), 15 ( BrAC Control = 0.028, BrAC GLP-1RA = 0.013, t(113) = 2.98, p = 0.028) and 20 min (BrAC Control = 0.037, BrAC GLP-1RA = 0.017, t(113) = 3.87, p = 0.001) in the GLP-1RA group as compared to the control group